Agilix Pockets $21M in Series B Financing Round

genomeweb
360dx

Agilix Pockets $21M in Series B Financing Round

Dec 17, 2001

NEW YORK, Dec. 17 - Functional genomics and proteomics technology developer Agilix has closed a Series B financing round worth $20.8 million, the firm said on Monday.

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

Swift Biosciences, Genomenon to Co-Market NGS Panel Design Service
NIH Issues Funding Announcement for Genome Centers for All of Us Research Program
Open Medicine Foundation Commits $1.8M to Research ME/CFS at Harvard Hospitals
Rainbow Genomics, Color Partner on Genetic Testing in Hong Kong
Intel, Institut Curie Partner on High-Performance Computing, AI for Genomic Medicine
Strata Oncology Raises $26M in Series B Financing Round

The Scan

Twisting the Results

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Quickly, Quickly

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

'Right to Try' Heads Toward Law

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

This Week in Genome Research

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.

Main menu